345432 <common-name>[2-[(3s,5r,8r,9s,10s,13r,14s,17r)-3-acetyloxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] prop-2-enoate</common-name> <description>[2-[(3s,5r,8r,9s,10s,13r,14s,17r)-3-acetyloxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] prop-2-enoate is a compound with the formula C26H38O6. It has an average molecular weight of 446.60 g/mol.</description> <cas>67462-32-2</cas> <pubchem-id>3051368</pubchem-id> <chemical-formula>C26H38O6</chemical-formula> <weight>446.6</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T08:10:55Z</created-at> <updated-at type="dateTime">2026-08-31T08:10:55Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC(=O)OC1CCC2(C(C1)CCC3C2CCC4(C3(CCC4C(=O)COC(=O)C=C)O)C)C</moldb-smiles> <moldb-formula>C26H38O6</moldb-formula> <moldb-inchi>InChI=1S/C26H38O6/c1-5-23(29)31-15-22(28)21-10-13-26(30)20-7-6-17-14-18(32-16(2)27)8-11-24(17,3)19(20)9-12-25(21,26)4/h5,17-21,30H,1,6-15H2,2-4H3/t17-,18+,19+,20-,21+,24+,25-,26+/m1/s1</moldb-inchi> <moldb-inchikey>LEIGTUZLBHBSPM-JHOXUQFISA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">446.2668389</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>4.3</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM341325</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>[2-[(3s,5r,8r,9s,10s,13r,14s,17r)-3-acetyloxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] prop-2-enoate</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Lipids and lipid-like molecules</superklass> <klass>Steroids and steroid derivatives</klass> <subklass>Steroid esters</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0295790</sync-id> <structure-inchikey>LEIGTUZLBHBSPM-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>400000000008000200001800000900040000000000000000000004000000000000000000000000000000000000000000000000000000000000208000140c00000102000000800000000000000200000002003000000000000000000000000000110000000000000000000000000000200000001000000008000005000100800480040000000000002000000202000000000000000000200000004200008000000040800080082000000000000000008000020000400000000000000000000000000000000000000000400000000000000000000000000000000000000a0000000000000000000000000000400000001000000080000080000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAgAAAAIwAAAIABBgBgAAAAAQMGACgAAAAD BAgAKAAAAAMCCAAoAAAAAwIGAGAAAAADAQYAYAAAAAICBgBgAAAAAgIGACAA AAAEBgBgAAAAAwEGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIGAGAAAAADAQYA YAAAAAMBBgBgAAAAAgIGAGAAAAACAgYAIAAAAAQGACAAAAAEBgBgAAAAAgIG AGAAAAACAgYAYAAAAAMBBgAoAAAAAwQIACgAAAADAgYAYAAAAAICCAAoAAAA AwIGACgAAAADBAgAKAAAAAMCBgBoAAAAAwMBBgBoAAAAAwICCABgAAAAAQEG AGAAAAABAwYAYAAAAAEDCwABAAECKAIBAyADBAAEBQAFBgAGBwAHCAAICQAI CgAKCwALDAAMDQANDgAODwAPEAAQEQAREgASEwATFAAUFQAVFggCFRcAFxgA GBkgGRooAhkbIBscKAIRHQAQHgAHHwAJBAANBwARDAAUEABCBAAAAAYECQgH BgUGCgsMDQcIBg4PEBEMDQUSERAUExcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:44:29Z</structure-indexed-at> </compound>